Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 191 Records) |
Query Trace: Counseling and BRCA2[original query] |
---|
Germline mutations in Black patients with ovarian, fallopian tube and primary peritoneal carcinomas. Gynecologic oncology 2021 8 163 (1): 130-133. Somasegar Sahana, Weiss Arielle S, Norquist Barbara M, Khasnavis Nithisha, Radke Marc, Manhardt Enna, Pennil Christopher, Pennington Kathryn P, Eckert Mark A, Chryplewicz Agnieszka, Lengyel Ernst, Swisher Elizabeth |
A novel germline BRCA2 mutation in a Chinese patient with prostate cancer sensitive to platinum chemotherapy: a case report. BMC urology 2021 8 21 (1): 114. Jiang Lijuan, Bai Zunguang, Zhu Shoulun, Zhao Tingting, Yang Yining, Li Zhiyong, Chen Dong, Wu Zhiming, Wang Yanjun, Zhou Fangjian, Li Yongho |
Preliminary results of targeted sequencing of BRCA1 and BRCA2 in a cohort of breast cancer families: New insight into pathogenic variants in patients and at?risk relatives. Molecular medicine reports 2021 Sep 24 (3): . Saied Marwa H, Elkaffash Dalal, Fadl Reham, Haleem Reham Abdel, Refeat Amal, Ibrahim Inas, Tahoun Mona, Elkayal Alyaa, Tayae Em |
Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan. Scientific reports 2021 Jul 11 (1): 14906. Abdel-Razeq Hikmat, Abujamous Lama, Abunasser Mahmoud, Edaily Sara, Bater Ray |
Mutational profile of hereditary breast and ovarian cancer - Establishing genetic testing guidelines in a developing country. Current problems in cancer 2021 7 46 (1): 100767. Krivokuca Ana, Mihajlovic Milica, Susnjar Snezana, Spasojevic Ivana Bozovic, Minic Ivana, Popovic Lazar, Brankovic-Magic Mirja |
Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort. The Prostate 2021 7 81 (13): 1002-1008. Wei Jun, Yang Wancai, Shi Zhuqing, Lu Lucy, Wang Qiang, Resurreccion W Kyle, Engelmann Valentina, Zheng S Lilly, Hulick Peter J, Cooney Kathleen A, Isaacs William B, Helfand Brian T, Lu Jim, Xu Jianfe |
Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study. Clinical and translational gastroenterology 2021 Oct 12 (10): e00414. Uson Pedro L S, Samadder N Jewel, Riegert-Johnson Douglas, Boardman Lisa, Borad Mitesh J, Ahn Daniel, Sonbol Mohamad B, Faigel Douglas O, Fukami Norio, Pannala Rahul, Kunze Katie, Golafshar Michael, Klint Margaret, Esplin Edward D, Nussbaum Robert L, Stewart A Keith, Bekaii-Saab Tani |
Communication processes about predictive genetic testing within high-risk breast cancer families: a two-phase study design. Scientific reports 2021 Oct 11 (1): 20178. Blomen Chiara L, Pott Aliaksandra, Volk Alexander E, Budäus Lars, Witzel Isabe |
Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic Mutations. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2022 Jun . Ahearn Thomas U, Choudhury Parichoy Pal, Derkach Andriy, Wiafe-Addai Beatrice, Awuah Baffour, Yarney Joel, Edusei Lawrence, Titiloye Nicholas, Adjei Ernest, Vanderpuye Verna, Aitpillah Francis, Dedey Florence, Oppong Joseph, Osei-Bonsu Ernest Baawuah, Duggan Máire A, Brinton Louise A, Allen Jamie, Luccarini Craig, Baynes Caroline, Carvalho Sara, Dunning Alison M, Davis Lynn Brittny C, Chanock Stephen J, Hicks Belynda D, Yeager Meredith, Chatterjee Nilanjan, Biritwum Richard, Clegg-Lamptey Joe Nat, Nyarko Kofi, Wiafe Seth, Ansong Daniel, Easton Douglas F, Figueroa Jonine D, Garcia-Closas Montserr |
Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2022 4 31 (7): 1450-1459. Mukherjee Semanti, Bandlamudi Chaitanya, Hellmann Matthew D, Kemel Yelena, Drill Esther, Rizvi Hira, Tkachuk Kaitlyn, Khurram Aliya, Walsh Michael F, Zauderer Marjorie G, Mandelker Diana, Topka Sabine, Zehir Ahmet, Srinivasan Preethi, Esai Selvan Myvizhi, Carlo Maria I, Cadoo Karen A, Latham Alicia, Hamilton Jada G, Liu Ying L, Lipkin Steven M, Belhadj Sami, Bond Gareth L, Gümü? Zeynep H, Klein Robert J, Ladanyi Marc, Solit David B, Robson Mark E, Jones David R, Kris Mark G, Vijai Joseph, Stadler Zsofia K, Amos Christopher I, Taylor Barry S, Berger Michael F, Rudin Charles M, Offit Kenne |
Population-based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants. Molecular genetics & genomic medicine 2022 3 10 (6): e1928. Castillo Cecilia, Artagaveytia Nora, Brignoni Lucia, Laitman Yael, Camejo Natalia, Hernández Ana Laura, Krygier Gabriel, Cayota Alfonso, Delgado Lucia, Friedman Eit |
A BRCA1 Splice Site Variant Responsible for Familial Ovarian Cancer in a Han-Chinese Family. Current medical science 2022 3 42 (3): 666-672. Hu Peng-Zhi, Chen Xiang-Yu, Xiong Wei, Yang Zhi-Jian, Li Xiao-Rong, Deng Wen-Zhi, Gong Li-Na, Deng Hao, Yuan La-M |
Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women. JCO precision oncology 2022 2 1 1-12. Kurian Allison W, Hughes Elisha, Handorf Elizabeth A, Gutin Alexander, Allen Brian, Hartman Anne-Renee, Hall Michael |
Evaluation of family history in individuals with heterozygous BRCA pathogenic variants diagnosed with breast or ovarian cancer in a single center in Italy. Molecular genetics & genomic medicine 2022 10 10 (12): e2071. Negri Serena, De Ponti Elena, Sina Federica Paola, Sala Elena, Dell'Oro Cristina, Roversi Gaia, Lazzarin Sara, Delle Marchette Martina, Inzoli Alesssandra, Toso Claudia, Fumagalli Simona, Campanella Maria, Kotsopoulos Joanne, Fruscio Robe |
Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian Cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing? International journal of molecular sciences 2022 10 23 (19): . Infante Mar, Arranz-Ledo Mónica, Lastra Enrique, Abella Luis Enrique, Ferreira Raquel, Orozco Marta, Hernández Lara, Martínez Noemí, Durán Merced |
Germline Variants in 32 Cancer-Related Genes among 700 Chinese Breast Cancer Patients by Next-Generation Sequencing: A Clinic-Based, Observational Study. International journal of molecular sciences 2022 Sep 23 (19): . Yang Liu, Xie Fei, Liu Chang, Zhao Jin, Hu Taobo, Wu Jinbo, Zhao Xiaotao, Wang S |
Genetic Counseling, Screening and Risk-Reducing Surgery in Patients with Primary Breast Cancer and Germline BRCA Mutations: Unmet Needs in Low- and Middle-Income Countries. European journal of breast health 2022 1 18 (1): 16-20. Moukadem Hiba A, Al Masry Ahmad, Atwani Rula W, Kreidieh Firas, Khalil Lana E, Saroufim Rita, Daouk Sarah, Dalle Iman Abou, El Saghir Nagi |
Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience. Genes 2023 5 14 (5): . Mariarosaria Calvello, Monica Marabelli, Sara Gandini, Elena Marino, Loris Bernard, Matteo Dal Molin, Giulia Di Cola, Cristina Zanzottera, Giovanni Corso, Nicola Fazio, Lorenzo Gervaso, Uberto Fumagalli Romario, Massimo Barberis, Aliana Guerrieri-Gonzaga, Lucio Bertario, Davide Serrano, Bernardo Bonan |
Increased prevalence of the founder BRCA1 c.5309G>T and recurrent BRCA2 c.1310_1313delAAGA mutations in breast cancer families from Northerstern region of Morocco: evidence of geographical specificity and high relevance for genetic counseling. BMC cancer 2023 4 23 (1): 339. Melki Rahma, Melloul Marouane, Aissaoui Souria, El Harroudi Tijani, Boukhatem Noureddi |
BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil. Breast cancer research and treatment 2023 3 . Mazzonetto Patricia, Milanezi Fernanda, D'Andrea Mariana, Martins Silvia, Monfredini Priscilla M, Dos Santos Silva Juliana, Perrone Eduardo, Villela Darine, Schnabel Beatriz, Nakano Viviane, Palmero Edenir Inez, Braggio Esteban, Cavalcanti Thereza L, Guida Gustavo, Migliavacca Michele P, Scapulatempo-Neto Cristovam, Zalcberg Ila |
Germline Mutations Landscape in a Cohort of the State of Minas Gerais, Brazil, in Patients Who Underwent Genetic Counseling for Gynecological and Breast Cancer. Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 2023 3 45 (2): 74-81. Carvalho Camila Martins de, Braga Letícia da Conceição, Silva Luciana Maria, Chami Anisse Marques, Silva Filho Agnaldo Lopes |
New pathogenic germline variants identified in mesothelioma. Lung cancer (Amsterdam, Netherlands) 2023 3 179 107172. Belcaid Laila, Bertelsen Birgitte, Wadt Karin, Tuxen Ida, Spanggaard Iben, Højgaard Martin, Benn Sørensen Jens, Ravn Jesper, Lassen Ulrik, Cilius Nielsen Finn, Rohrberg Kristoffer, Westmose Yde Christi |
Ten-point guide on the management of healthy women carrying BRCA1/2 mutations. Maturitas 2023 3 171 21-23. Caretto Marta, Casula Elisa, Catrambone Ilaria, Giannini Andrea, Simoncini Tomma |
Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico. Frontiers in genetics 2023 2 14 1094260. Díaz-Velásquez Clara Estela, Gitler Rina, Antoniano Adriana, Kershenovich Sefchovich Ronny, De La Cruz-Montoya Aldo Hugo, Martínez-Gregorio Héctor, Rojas-Jiménez Ernesto Arturo, Cortez Cardoso Penha Ricardo, Terrazas Luis Ignacio, Wegman-Ostrosky Talia, Levi-Lahad Ephrat, Zabaleta Jovanny, Perdomo Sandra, Vaca-Paniagua Feli |
Association of Reported Candidate Monogenic Genes With Lung Cancer Risk. Clinical lung cancer 2023 2 . Rifkin Andrew S, Less Ethan M, Wei Jun, Shi Zhuqing, Zheng Siqun Lilly, Helfand Brian T, Hulick Peter J, Krantz Seth B, Xu Jianfe |
[BRCA2 Mutation Profile in a Proband with Hereditary Breast and Ovarian Cancer-Two Germline Pathogenic Variants Aligned in the Cis Position]. Gan to kagaku ryoho. Cancer & chemotherapy 2023 11 50 (10): 1089-1091. Seigo Yukisawa, Toshiyuki Kakinuma, Junko Yotsumoto, Kentaro Kawakami, Junji Furukawa, Hiroharu Shinoza |
Genetic, Surgical and Oncological Approach to Breast Cancer, with BRCA1, BRCA2, CDH1, PALB2, PTEN and TP53 Variants. European journal of breast health 2023 1 19 (1): 55-69. Suba??o?lu Asl?, Güç Zeynep Gülsüm, Gür Emine Özlem, Tekindal Mustafa Agah, Atahan Murat Kem |
Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants. JAMA network open 2024 4 7 (4): e247421. Zhenzhen Zhang, Shangyuan Ye, Sarah M Bernhardt, Heidi D Nelson, Ellen M Velie, Virginia F Borges, Emma R Woodward, D Gareth R Evans, Pepper J Sched |
Targeted genotyping for recurring variants in cancer susceptibility genes in non-Ashkenazi Jewish patients with breast cancer diagnosed ?50 years. Cancer 2024 4 . Rinat Bernstein-Molho, Narmeen Abu Shhada, Yael Laitman, Iris Netzer, Shelley Shoval, Eitan Friedm |
Genetic Risk Factors for Early-Onset Merkel Cell Carcinoma. JAMA dermatology 2024 1 . Noreen Mohsin, Devin Hunt, Jia Yan, Austin J Jabbour, Paul Nghiem, Jaehyuk Choi, Yue Zhang, Alexandra F Freeman, Jenna R E Bergerson, Stefania Dell'Orso, Kristina Lachance, Rima Kulikauskas, Loren Collado, Wenjia Cao, Justin Lack, Morgan Similuk, Bryce A Seifert, Rajarshi Ghosh, Magdalena A Walkiewicz, Isaac Browne |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: